欧洲核医学与分子成像杂志 SCIE

期刊简介预计审稿时间： 约3月

The aim of the European Journal of Nuclear Medicine and Molecular Imaging is to provide a forum for the exchange of clinical and scientific information for the imaging community and allied professions involved in the functional, metabolic and molecular investigation of diseases. The European Journal of Nuclear Medicine and Molecular Imaging will remain of primary interest to those practicing the field of imaging, radiopharmaceutical therapy and image guided therapy. The field of interest includes advanced imaging analyses techniques and artificial intelligence application in the field of imaging. Reports on original works related to physics, dosimetry, radiation biology, radiochemistry and pharmacy, will be considered in the field of interest of the EJNMMI. The Journal will welcome original material reflecting the field of molecular imaging probes, reporter gene assays, cell trafficking, targeting of endogenous gene expression and antisense methodologies.

The Journal will continue to publish in depth Reviews of topical interest, Short communications, Controversies, interesting images and Letters to the editor. Case reports are not published.

The journal publishes the following article types:

Original article,

Review article,

Letter to the Editor,

Guidelines,

Controversies,

Image of the month,

Short Communications,

Editorials

《欧洲核医学与分子成像杂志》旨在为影像界和相关专业提供一个交流临床和科学信息的论坛，这些专业涉及疾病的功能、代谢和分子研究。《欧洲核医学与分子成像杂志》仍将主要吸引那些从事成像、放射性药物治疗和图像引导治疗领域的人士。该领域包括先进的成像分析技术和人工智能在成像领域的应用。与物理学、剂量测定、放射生物学、放射化学和药学相关的原创作品报告将被纳入 EJNMMI 的关注领域。该杂志将欢迎反映分子成像探针、报告基因检测、细胞运输、内源性基因表达靶向和反义方法领域的原创材料。

该杂志将继续发表深度专题评论、简短通讯、争议、有趣的图像和致编辑的信。病例报告不发表。

本期刊发表以下类型的文章：

原创文章，

评论文章，

致编辑的信，

指南，

争议，

本月图片，

简短通讯，

社论

《European Journal Of Nuclear Medicine And Molecular Imaging》(欧洲核医学与分子成像杂志)编辑部通讯方式为SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013。如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。